Drug – bio-affecting and body treating compositions – Conjugate or complex of monoclonal or polyclonal antibody,... – Conjugated via claimed linking group – bond – chelating agent,...
Patent
1978-04-17
1980-06-03
Brown, Johnnie R.
Drug, bio-affecting and body treating compositions
Conjugate or complex of monoclonal or polyclonal antibody,...
Conjugated via claimed linking group, bond, chelating agent,...
26034341, 424279, 424181, 536 4, 536 9, 536 17A, A61K 3171, A61K 31365, C07H 1708
Patent
active
042062055
ABSTRACT:
Derivatives of C-076 are described in which the C-076 molecule, a series of macrolides in which one of the substituents is a 4-(.alpha.-L-oleandrosyl)-.alpha.-L-oleandrose has one or both of the carbohydrate moieties removed therefrom. The compounds thus produced have profound anthelmintic, insecticidal, ectoparasiticidal and acaracidal activity and compositions for such use are also disclosed.
REFERENCES:
patent: 3923784 (1975-12-01), Kierstead et al.
patent: 3928387 (1975-12-01), Kierstead et al.
patent: 3939144 (1976-02-01), Radobolja et al.
patent: 3950360 (1976-04-01), Aoki et al.
patent: 4093629 (1978-06-01), Fisher
patent: 4134973 (1979-01-01), Fisher et al.
"Tetrahedron Letter," vol. 10, pp. 711-714, 1975.
"Jour. of Antibiotics," vol. 29, No. 6, 6/76, pp. 14-16 and pp. 35-42.
Albers-Schonberg George
Mrozik Helmut H.
Brown Johnnie R.
Merck & Co. , Inc.
Rose David L.
Westlake Harry E.
LandOfFree
Monosaccharide and aglycone derivatives of C-076 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Monosaccharide and aglycone derivatives of C-076, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monosaccharide and aglycone derivatives of C-076 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-715920